Scholtz & Company, LLC Zoetis Inc. Transaction History
Scholtz & Company, LLC
- $226 Million
- Q1 2024
A detailed history of Scholtz & Company, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Scholtz & Company, LLC holds 24,772 shares of ZTS stock, worth $4.32 Million. This represents 1.86% of its overall portfolio holdings.
Number of Shares
24,772
Previous 21,202
16.84%
Holding current value
$4.32 Million
Previous $4.18 Million
0.17%
% of portfolio
1.86%
Previous 2.08%
Shares
7 transactions
Others Institutions Holding ZTS
# of Institutions
1,862Shares Held
416MCall Options Held
1.13MPut Options Held
1.81M-
Vanguard Group Inc Valley Forge, PA40.7MShares$7.1 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY36.7MShares$6.4 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.6MShares$3.41 Billion0.15% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL16.2MShares$2.81 Billion2.46% of portfolio
-
Bank Of America Corp Charlotte, NC14MShares$2.43 Billion0.22% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $81.6B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...